Background: We assessed bleb morphology and the intraocular pressure (IOP)-lowering effect of trabeculectomy with ologen compared to mitomycin C (MMC) in juvenile open-angle glaucoma (JOAG). Methods: This is a prospective interventional comparative study conducted on 40 eyes (20 patients) with medically uncontrolled JOAG, randomly operating one eye for trabeculectomy with ologen (group A: 20 eyes) and the other with MMC (group B: 20 eyes). IOP measurement, SITA standard perimetry, and spectral domain optical coherence tomography (OCT) for retinal nerve fiber layer (RNFL) thickness were all done pre- and postoperatively. Postoperative blebs were assessed clinically using the Moorfields bleb grading system (MBGS) and anterior segment OCT (AS-OCT). All patients were examined for up to 1 year postoperatively. Results: The mean postoperative IOP was statistically significantly lower than the mean preoperative IOP at each follow-up in each group. At 1 year, the mean postoperative IOP was significantly lower in group A. According to the MBGS, blebs with an ologen implant showed significantly better scoring than those with MMC. AS-OCT showed that ologen-induced blebs had significantly more fluid-filled spaces, cleavage planes, and less fibrosis. Conclusion: Ologen resulted in a lower long-term postoperative IOP, a better bleb morphology, and fewer complications. Our results suggest that ologen may be a useful alternative to MMC in JOAG.

Keywords:
Trabeculectomy, Juvenile glaucoma, Ologen, Mitomycin C, Moorfields bleb grading system, Optical coherence tomography
1.
Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R: Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology 2000;107:422-429.
2.
Reibaldi A, Uva MG, Longo A: Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-C in primary open-angle glaucoma. Br J Ophthalmol 2008;92:1666-1670.
3.
Nash DL, Crouch ER, Crouch ER Jr: Comparison of EX-PRESS shunt and trabeculectomy with mitomycin-C in congenital and juvenile glaucoma. J Glaucoma 2016;26:e58-e63.
4.
Johnson MS, Sarkisian SR Jr: Using a collagen matrix implant (ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review. J Glaucoma 2014;23:649-652.
5.
Hsu WC, Ritch R, Krupin T, Chen HS: Tissue bioengineering for surgical bleb defects: an animal study. Graefes Arch Clin Exp Ophthalmol 2008;246:709-717.
6.
Marey HM, Mandour SS, Ellakwa AF: Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma. J Ocul Pharmacol Ther 2013;29:330-334.
7.
Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS: Comparison of outcomes of trabeculectomy with mitomycin C versus ologen implant in primary glaucoma. Indian J Ophthalmol 2013;61:338-342.
8.
Nilforushan N, Yadegari M, Hodjat P: Comparison of the success rate of trabeculectomy with OculusGen versus trabeculectomy with mitomycin C. Iran J Ophthalmol 2011;23:3-12.
9.
Cillino S, Di Pace F, Cillino G, Casuccio A: Biodegradable collagen matrix implant vs. mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial. Eye (Lond) 2011;25:1598-1606.
10.
Ji Q, Qi B, Liu L, Guo X, and Zhong J: Efficacy and safety of ologen implant versus mitomycin C in primary trabeculectomy: a meta-analysis of randomized clinical trials. J Glaucoma 2015;24:e88-e94.
11.
Perez CI, Mellado F, Jones A, Colvin R: Trabeculectomy combined with collagen matrix implant (ologen). J Glaucoma 2016;26:54-58.
12.
El-Saied HM, Abdelhakim MA: Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study. Eye (Lond) 2016;30:1126-1134.
13.
Elhefney EM, Al-Sharkawy HT, Kishk HM, Abouelkheir H: Safety and efficacy of collagen matrix implantation in infantile glaucoma. Eur J Ophthalmol 2016, DOI: 10.5301/ejo. 5000859.
14.
Dada T, Kusumesh R, Bali SJ, Sharma S, Sobti A, Arora V, Panda A: Trabeculectomy with combined use of subconjunctival collagen implant and low-dose mitomycin C. J Glaucoma 2013;22:659-662.
15.
Min JK, Kee CW, Sohn SW, Lee HJ, Woo JM, Yim JH: Surgical outcome of mitomycin C-soaked collagen matrix implant in trabeculectomy. J Glaucoma 2013;22:456-462.
16.
Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T: Outcomes of trabeculectomy augmented with subconjunctival and subscleral ologen implantation in primary advanced glaucoma. J Glaucoma 2016;26:8-14.
17.
Boey PY, Narayanaswamy A, Zheng C, Perera SA, Htoon HM, Tun TA, Seah SK, Wong TT, Aung T: Imaging of blebs after phacotrabeculectomy with ologen collagen matrix implants. Br J Ophthalmol 2011;95:340-344.
18.
Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS: A prospective randomized trial of trabeculectomy using mitomycin C versus an ologen implant in open angle glaucoma. Eye 2010;24:1449-1457.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.